MediWound (MDWD) Current Assets (2016 - 2026)
MediWound (MDWD) posted Current Assets of $43.0 million for Q2 2026, down 17.66% on a QoQ basis from $52.2 million in Q1 2026, and little changed year-over-year from $43.1 million in Q2 2025.
Analysis
MediWound (MDWD) Current Assets (2016 - 2026) Analysis & Trends
MediWound has reported Current Assets for 11 years, with the latest figure at $43.0 million in Q2 2026.
- On a quarterly basis, Current Assets changed 0.3% year-over-year to $43.0 million in Q2 2026; TTM through Jun 2026 was $43.0 million, a 0.3% change from a year earlier, with the FY2025 full-year figure at $60.0 million, up 14.96% from the prior year.
- Current Assets was $43.0 million for Q2 2026 at MediWound, down from $52.2 million in the prior quarter.
- The five-year high for Current Assets was $69.5 million in Q3 2025, with the low at $16.8 million in Q2 2022.
- Average Current Assets over 5 years is $46.4 million, with a median of $48.4 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Current Assets soared 245.37% in 2023, then plunged 35.73% in 2024.
- Over 5 years, Current Assets stood at $45.8 million in 2022, then grew by 8.41% to $49.7 million in 2023, then advanced by 4.97% to $52.2 million in 2024, then climbed by 14.96% to $60.0 million in 2025, then dropped by 28.37% to $43.0 million in 2026.
- The last three Current Assets figures came in at $43.0 million (Q2 2026), $52.2 million (Q1 2026), and $60.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 4.74 Bn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 42.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.95 Mn |
| Mar 31, 2026 | 52.17 Mn |
| Dec 31, 2025 | 59.96 Mn |
| Sep 30, 2025 | 69.53 Mn |
| Jun 30, 2025 | 43.08 Mn |
| Mar 31, 2025 | 47.02 Mn |
| Dec 31, 2024 | 52.16 Mn |
| Sep 30, 2024 | 53.89 Mn |
| Jun 30, 2024 | 37.31 Mn |
| Mar 31, 2024 | 44.20 Mn |
| Dec 31, 2023 | 49.70 Mn |
| Sep 30, 2023 | 53.25 Mn |
| Jun 30, 2023 | 58.05 Mn |
| Mar 31, 2023 | 63.27 Mn |
| Dec 31, 2022 | 45.84 Mn |
| Sep 30, 2022 | 24.45 Mn |
| Jun 30, 2022 | 16.81 Mn |
| Mar 31, 2022 | 21.96 Mn |
| Dec 31, 2021 | 14.95 Mn |
| Sep 30, 2021 | 18.67 Mn |